Us Epidemic Disease Infection Control Solution Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Epidemic Disease Infection Control Solution Market was valued at USD 10.5 Billion in 2022 and is projected to reach USD 22.3 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030.
The United States is witnessing a significant surge in the epidemic disease infection control solution market, driven by escalating healthcare-associated infections (HAIs) and the emergence of drug-resistant pathogens. This growth trajectory underscores the critical need for advanced infection control measures to safeguard public health.
Recent data reveals that the U.S. infection control market is projected to reach a value of approximately $12.89 billion by 2025, expanding at a compound annual growth rate (CAGR) of 8.06%. This upward trend is largely attributed to the increasing prevalence of HAIs, which affect about 1 in 31 hospital patients daily, leading to severe health complications and extended hospital stays.
Several factors contribute to this market expansion:
Rise in Surgical Procedures: The growing number of surgical interventions necessitates stringent infection control protocols to prevent postoperative infections.
Aging Population: With nearly 20% of the U.S. population aged above 60, there is a heightened demand for healthcare services, subsequently increasing the need for effective infection control solutions.
Emergence of Drug-Resistant Infections: The Centers for Disease Control and Prevention (CDC) reports that drug-resistant bacteria cause over 23,000 deaths annually in the U.S., emphasizing the urgency for robust infection prevention strategies.
In response to these challenges, the market offers a diverse range of products and services, including:
Cleaning and Disinfection Products: Advanced disinfectants and sterilization equipment designed to eliminate pathogens from medical instruments and surfaces.
Protective Equipment: Personal protective equipment (PPE) such as gloves, masks, and gowns that serve as barriers against infection transmission.
Endoscope Reprocessing Products: Specialized solutions ensuring the safe and effective decontamination of endoscopic devices.
Moreover, technological advancements are revolutionizing infection control practices. The development of long-acting injectable drugs, like lenacapavir, which has demonstrated a 96% reduction in HIV infections during trials, showcases the potential of innovative treatments in controlling epidemic diseases. Additionally, the approval of at-home diagnostic tests, such as the $30 syphilis test, empowers individuals to detect infections early, facilitating prompt medical intervention.
However, the market faces challenges, including a lack of awareness regarding proper usage of infection control products and financial constraints affecting healthcare facilities' ability to adopt advanced solutions. Addressing these issues through comprehensive education and policy reforms is essential to enhance the effectiveness of infection control measures nationwide.
In my professional experience as a healthcare consultant, I have observed that facilities investing in continuous staff training and adopting state-of-the-art infection control technologies not only reduce HAIs but also improve patient outcomes and operational efficiency. Emphasizing a culture of hygiene and proactive infection prevention is paramount in combating the spread of epidemic diseases.
As the U.S. continues to confront evolving infectious threats, the infection control solution market stands as a pivotal component in safeguarding public health, necessitating ongoing innovation, investment, and education to effectively mitigate the impact of epidemic diseases.
Get an In-Depth Research Analysis of the Global Epidemic Disease Infection Control Solution Market Size And Forecast [2025-2032]
Â
3M Company
Honeywell
Advanced Sterilization Products
Belimed AG
Cantel Medical Corporation
Ecolab
Inc.
Getinge AB (Getinge Group)
Halyard Health
Inc.
Matachana Group
Metrex Research LLC
Pal International Ltd.
Reckitt Benckiser Group PLC
Sotera Health LLC
Steris
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Epidemic Disease Infection Control Solution Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Epidemic Disease Infection Control Solution Market
Preventive Solutions
Vaccines
Sanitizers and Disinfectants
Personal Protective Equipment (PPE)
Healthcare Facilities
Hospitals
Clinics
Pharmacies
Viral Infections
Influenza
COVID-19
HIV/AIDS
Direct Sales
Hospital Procurement
Corporate Supply Contracts
Conventional Technologies
Traditional Diagnostic Tests
Standard Treatment Protocols
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Epidemic Disease Infection Control Solution Market Research Analysis
1. Introduction of the Global Epidemic Disease Infection Control Solution Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Epidemic Disease Infection Control Solution Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Epidemic Disease Infection Control Solution Market, By Type
6. Global Epidemic Disease Infection Control Solution Market, By Application
7. Global Epidemic Disease Infection Control Solution Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Epidemic Disease Infection Control Solution Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/